Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Hims & Hers Health Inc (NY: HIMS )

23.41 -0.21 (-0.89%)
Official Closing Price Updated: 7:00 PM EST, Nov 8, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 17,983,796
Open 23.60
Bid (Size) 23.40 (1)
Ask (Size) 23.47 (30)
Prev. Close 23.62
Today's Range 21.41 - 23.61
52wk Range 6.580 - 25.74
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Stock Market Surges To Highs On Trump Election; Fed Cuts Rates, Palantir Soars: Weekly Review
A Fed rate cut and a slew of big earnings reports filled out a busy week. 
Via Investor's Business Daily
Topics Economy Government
Exposures Interest Rates Political
After Another Blowout Quarter of Surging Revenue, Is Hims & Hers Stock a Once-in-a-Decade Buy?
Hims & Hers strong performance involves much more than just GLP-1 drugs. 
Via The Motley Fool

Performance

YTD
+142.84%
+142.84%
1 Month
+31.15%
+31.15%
3 Month
+46.59%
+46.59%
6 Month
+81.61%
+81.61%
1 Year
+243.76%
+243.76%

More News

Read More
Why HIMS & HERS HEALTH INC (NYSE:HIMS) qualifies as a high growth stock.
Via Chartmill
Assessing Hims & Hers Health: Insights From 7 Financial Analysts
Via Benzinga
Decoding Hims & Hers Health's Options Activity: What's the Big Picture?
Via Benzinga
Smart Money Is Betting Big In HIMS Options
Via Benzinga
A Look Into Hims & Hers Health Inc's Price Over Earnings
Via Benzinga
Missed Out on Eli Lilly? Buy This Amazing Growth Stock Instead
Via The Motley Fool
Hims & Hers: Why This Healthcare Stock’s Growth Makes It a Buy
Via MarketBeat
Topics ETFs Economy
Exposures Economy Interest Rates
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
What's Going On With Hims & Hers Health Stock Tuesday?
Via Benzinga
Charter Communications To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Tuesday
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Palantir, Trump Media, Hims & Hers Health, NXP Semiconductors, And Tesla: Why These 5 Stocks Are On Investors' Radars Today
Via Benzinga
Topics Government Stocks
Exposures Political US Equities
Hims & Hers Health Reports Better-Than-Expected Q3 Results: Details
Via Benzinga
IBD 50's No. 2 Stock, Hims & Hers, Smashes Estimates On 'Robust' Obesity Trajectory
Via Investor's Business Daily
Hims & Hers Health, Inc. Reports Third Quarter 2024 Financial Results
From Hims & Hers
Via Business Wire
What's Going On With Hims & Hers Health Stock Monday?
Via Benzinga
Hims & Hers Health Stock Is Trading Lower Wednesday: Here's Why
Via Benzinga
Exposures Product Safety
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Could This Magnificent Pharma Stock 10x in the Next 5 Years?
Via The Motley Fool
How Compounded Treatments Are Helping Hims & Hers Customers Meet Their Weight Loss Goals
From Hims & Hers
Via Business Wire
Top 3 Stocks Institutions Are Buying Right Now
Via MarketBeat
Hims & Hers Stock Dropped: Here's What You Need to Know
Via The Motley Fool
Ozempic And Wegovy Maker Novo Nordisk Asks FDA To Halt Production Of Compounded Fat Loss Drugs Due To Their 'Inherent Complexity'
Via Benzinga
Exposures Product Safety
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.